{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T02:48:28Z","timestamp":1785206908901,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the fund of Key Laboratory of Acupuncture and Medicine Research (Nanjing University of Chinese Medicine), Ministry of Education","award":["201710zykf03"],"award-info":[{"award-number":["201710zykf03"]}]},{"name":"Colleges and Universities Natural Science Foundation of Jiangsu Province","award":["19KJB320018"],"award-info":[{"award-number":["19KJB320018"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Sciences Foundation of China","doi-asserted-by":"crossref","award":["31730031"],"award-info":[{"award-number":["31730031"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Parkinson\u2019s disease (PD) is a neurodegenerative disease caused by a variety of unclear complex pathogenic factors. The 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine\/probenecid (MPTP\/p)-induced progressive PD mice is a well-recognized classic model for studying PD, but the molecular toxicology of this model is still unclear. Here, for the first time, we report gradual neurodegenerative processes in MPTP\/p-induced progressive PD mice model using RNA-seq. Transcriptional responses are orchestrated to regulate the expression of many genes in substantia nigra, such as <jats:italic>Ntf3<\/jats:italic>, <jats:italic>Pitx3<\/jats:italic>, <jats:italic>Th<\/jats:italic>, and <jats:italic>Drd2<\/jats:italic>, leading to the degeneration of dopaminergic neurons at last. We proposed that the established model could be divided into three phases based on their molecular toxicological features: \u201cthe stress response phase\u201d which maintained the microenvironment homeostasis, \u201cthe pre-neurodegenerative phase\u201d which demonstrated observed MPTP\/p cytotoxicity and gradual degeneration of dopaminergic neurons, and \u201cthe neurodegenerative phase\u201d which reflected distinct damage and dopaminergic neuron apoptotic process. Glia cells exhibited a certain protective effect on dopaminergic neurons in 3rd and 6th MPTP\/p-induced cytotoxicity. But in 10th MPTP\/p injection, glia cells play a promoting role in PD and tissue damages caused by oxidative stress. This study also indicated that the substantia nigra of PD mice showed unique patterns of changes at each stage. Moreover, neurotrophic signaling pathway, ECM-receptor interaction, oxidative phosphorylation, apoptosis and necroptosis were enriched at 3rd and 6th MPTP\/p injection, which might be associated with the PD progress. This study provided an extensive data set of molecular toxicology for elucidating of PD progression and offered comprehensive theoretical knowledge for the development of new therapy.<\/jats:p>","DOI":"10.1007\/s12035-020-02128-5","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T06:02:41Z","timestamp":1601445761000},"page":"603-616","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Molecular Regulatory Mechanism and Toxicology of Neurodegenerative Processes in MPTP\/Probenecid-Induced Progressive Parkinson\u2019s Disease Mice Model Revealed by Transcriptome"],"prefix":"10.1007","volume":"58","author":[{"given":"Weiwei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2562-6275","authenticated-orcid":false,"given":"Xiaosong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,30]]},"reference":[{"issue":"6","key":"2128_CR1","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","volume":"33","author":"C Hawkes","year":"2007","unstructured":"Hawkes C, Tredici KD, Braak H (2007) Parkinson's disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol 33(6):599\u2013614. https:\/\/doi.org\/10.1111\/j.1365-2990.2007.00874.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2128_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fnana.2014.00155","volume":"8","author":"J Blesa","year":"2014","unstructured":"Blesa J, Przedborski S (2014) Parkinson's disease: nimal models and dopaminergic cell vulnerability. Front Neuroanat 8:155. https:\/\/doi.org\/10.3389\/fnana.2014.00155","journal-title":"Front Neuroanat"},{"issue":"3","key":"2128_CR3","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/mds.20727","volume":"21","author":"K Noyes","year":"2006","unstructured":"Noyes K, Liu H, Li Y, Holloway R, Dick AW (2006) Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries. Mov Disord 21(3):362\u2013372. https:\/\/doi.org\/10.1002\/mds.20727","journal-title":"Mov Disord"},{"issue":"3","key":"2128_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/mds.25292","volume":"28","author":"S Kowal","year":"2013","unstructured":"Kowal S, Dall T, Chakrabarti R, Storm M, Jain A (2013) The current and projected economic burden of Parkinson's disease in the United States. Mov Disord 28(3):311\u2013318. https:\/\/doi.org\/10.1002\/mds.25292","journal-title":"Mov Disord"},{"issue":"Pt 8","key":"2128_CR5","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1093\/brain\/awt192","volume":"136","author":"JH Kordower","year":"2013","unstructured":"Kordower JH, Olanow CW, Dodiya HB, Chu Y, Beach TG, Adler CH, Halliday GM, Bartus RT (2013) Disease duration and the integrity of the nigrostriatal system in Parkinson's disease. Brain 136(Pt 8):2419\u20132431. https:\/\/doi.org\/10.1093\/brain\/awt192","journal-title":"Brain"},{"issue":"4","key":"2128_CR6","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, Lee JH, Kim WR et al (2019) Transneuronal propagation of pathologic alpha-synuclein from the gut to the brain models Parkinson's disease. Neuron 103(4):627\u2013641 e627. https:\/\/doi.org\/10.1016\/j.neuron.2019.05.035","journal-title":"Neuron"},{"issue":"1","key":"2128_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, R\u00fcb U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 318(1):121\u2013134. https:\/\/doi.org\/10.1007\/s00441-004-0956-9","journal-title":"Cell Tissue Res"},{"issue":"12","key":"2128_CR8","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1002\/mds.27860","volume":"34","author":"P Krack","year":"2019","unstructured":"Krack P, Volkmann J, Tinkhauser G, Deuschl G (2019) Deep brain stimulation in movement disorders: from experimental surgery to evidence-based therapy. Mov Disord 34(12):1795\u20131810. https:\/\/doi.org\/10.1002\/mds.27860","journal-title":"Mov Disord"},{"key":"2128_CR9","doi-asserted-by":"publisher","unstructured":"Li S, Le W (2019) Parkinson's disease in traditional Chinese medicine. Lancet Neurol. https:\/\/doi.org\/10.1016\/s1474-4422(19)30224-8","DOI":"10.1016\/s1474-4422(19)30224-8"},{"issue":"7669","key":"2128_CR10","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nature23664","volume":"548","author":"T Kikuchi","year":"2017","unstructured":"Kikuchi T, Morizane A, Doi D, Magotani H, Onoe H, Hayashi T, Mizuma H, Takara S et al (2017) Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model. Nature 548(7669):592\u2013596. https:\/\/doi.org\/10.1038\/nature23664","journal-title":"Nature"},{"key":"2128_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.21037\/sci.2017.06.08","volume":"4","author":"V Dhivya","year":"2017","unstructured":"Dhivya V, Balachandar V (2017) Cell replacement therapy is the remedial solution for treating Parkinson's disease. Stem Cell Investig 4:59. https:\/\/doi.org\/10.21037\/sci.2017.06.08","journal-title":"Stem Cell Investig"},{"issue":"12","key":"2128_CR12","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1002\/mds.27865","volume":"34","author":"MA Sacheli","year":"2019","unstructured":"Sacheli MA, Neva JL, Lakhani B, Murray DK, Vafai N, Shahinfard E, English C, McCormick S et al (2019) Exercise increases caudate dopamine release and ventral striatal activation in Parkinson's disease. Mov Disord 34(12):1891\u20131900. https:\/\/doi.org\/10.1002\/mds.27865","journal-title":"Mov Disord"},{"key":"2128_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11010-011-0773-x","volume":"353","author":"M Nandhu","year":"2011","unstructured":"Nandhu M, Paul J, Kuruvila K, Abraham P, Antony S, Paulose C (2011) Glutamate and NMDA receptors activation leads to cerebellar dysfunction and impaired motor coordination in unilateral 6-hydroxydopamine lesioned Parkinson's rat: functional recovery with bone marrow cells, serotonin and GABA. Mol Cell Biochem 353:47\u201357. https:\/\/doi.org\/10.1007\/s11010-011-0773-x","journal-title":"Mol Cell Biochem"},{"issue":"9996","key":"2128_CR14","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/s0140-6736(14)61393-3","volume":"386","author":"L Kalia","year":"2015","unstructured":"Kalia L, Lang A (2015) Parkinson's disease. Lancet 386(9996):896\u2013912. https:\/\/doi.org\/10.1016\/s0140-6736(14)61393-3","journal-title":"Lancet"},{"issue":"5","key":"2128_CR15","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s12272-019-01133-0","volume":"42","author":"Y Lee","year":"2019","unstructured":"Lee Y, Lee S, Chang S, Lee J (2019) Significant roles of neuroinflammation in Parkinson's disease: therapeutic targets for PD prevention. Arch Pharm Res 42(5):416\u2013425. https:\/\/doi.org\/10.1007\/s12272-019-01133-0","journal-title":"Arch Pharm Res"},{"key":"2128_CR16","doi-asserted-by":"publisher","unstructured":"Bossers K, Meerhoff G, Balesar R, Dongen JV, Kruse C, Swaab D, Verhaagen (2009) Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death. Brain Pathol 19 (1):91\u2013107. doi:https:\/\/doi.org\/10.1111\/j.1750-3639.2008.00171.x","DOI":"10.1111\/j.1750-3639.2008.00171.x"},{"issue":"1","key":"2128_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/jcp.26865","volume":"234","author":"K Hassanzadeh","year":"2018","unstructured":"Hassanzadeh K, Rahimmi A (2018) Oxidative stress and neuroinflammation in the story of Parkinson's disease: could targeting these pathways write a good ending? J Cell Physiol 234(1):23\u201332. https:\/\/doi.org\/10.1002\/jcp.26865","journal-title":"J Cell Physiol"},{"issue":"9","key":"2128_CR18","doi-asserted-by":"publisher","first-page":"7229","DOI":"10.1007\/s12035-018-0907-1","volume":"55","author":"A Alieva","year":"2018","unstructured":"Alieva A, Zyrin V, Rudenok M, Kolacheva A, Shulskaya M, Ugryumov M, Slominsky P, Shadrina M (2018) Whole-transcriptome analysis of mouse models with MPTP-induced early stages of Parkinson's disease reveals stage-specific response of transcriptome and a possible role of myelin-linked genes in Neurodegeneration. Mol Neurobiol 55(9):7229\u20137241. https:\/\/doi.org\/10.1007\/s12035-018-0907-1","journal-title":"Mol Neurobiol"},{"key":"2128_CR19","doi-asserted-by":"publisher","unstructured":"Meredith G, Totterdell S, Potashkin J, Surmeier D (2008) Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol. Parkinsonism Relat Disord:S112\u2013S115. https:\/\/doi.org\/10.1016\/j.parkreldis.2008.04.012","DOI":"10.1016\/j.parkreldis.2008.04.012"},{"key":"2128_CR20","doi-asserted-by":"publisher","unstructured":"Schintu N, Frau L, Ibba M, Garau A, Carboni E, Carta A (2009) Progressive dopaminergic degeneration in the chronic MPTPp mouse model of Parkinson\u2019s disease. Neurotox Res 16(2):127\u2013139. https:\/\/doi.org\/10.1007\/s12640-009-9061-x","DOI":"10.1007\/s12640-009-9061-x"},{"issue":"15","key":"2128_CR21","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B (2014) Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30(15):2114\u20132120. https:\/\/doi.org\/10.1093\/bioinformatics\/btu170","journal-title":"Bioinformatics"},{"issue":"4","key":"2128_CR22","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL (2012) Fast gapped-read alignment with Bowtie 2. Nat Methods 9(4):357\u2013359. https:\/\/doi.org\/10.1038\/nmeth.1923","journal-title":"Nat Methods"},{"key":"2128_CR23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN (2011) RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12:323. https:\/\/doi.org\/10.1186\/1471-2105-12-323","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"2128_CR24","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1093\/bioinformatics\/btp612","volume":"26","author":"L Wang","year":"2010","unstructured":"Wang L, Feng Z, Wang X, Wang X, Zhang X (2010) DEGseq: an R package for identifying differentially expressed genes from RNA-seq data. Bioinformatics 26(1):136\u2013138. https:\/\/doi.org\/10.1093\/bioinformatics\/btp612","journal-title":"Bioinformatics"},{"issue":"18","key":"2128_CR25","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1093\/bioinformatics\/btx364","volume":"33","author":"JR Conway","year":"2017","unstructured":"Conway JR, Lex A, Gehlenborg N (2017) UpSetR: an R package for the visualization of intersecting sets and their properties. Bioinformatics 33(18):2938\u20132940. https:\/\/doi.org\/10.1093\/bioinformatics\/btx364","journal-title":"Bioinformatics"},{"key":"2128_CR26","doi-asserted-by":"publisher","unstructured":"Kumar L, ME Futschik (2007) Mfuzz: a software package for soft clustering of microarray data. Bioinformation 2 (1):5\u20137. doi:https:\/\/doi.org\/10.6026\/97320630002005","DOI":"10.6026\/97320630002005"},{"issue":"11","key":"2128_CR27","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498\u20132504. https:\/\/doi.org\/10.1101\/gr.1239303","journal-title":"Genome Res"},{"issue":"43","key":"2128_CR28","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102(43):15545\u201315550. https:\/\/doi.org\/10.1073\/pnas.0506580102","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2128_CR29","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1021\/acs.jproteome.8b00702","volume":"18","author":"NT Doncheva","year":"2019","unstructured":"Doncheva NT, Morris JH, Gorodkin J, Jensen LJ (2019) Cytoscape StringApp: network analysis and visualization of proteomics data. J Proteome Res 18(2):623\u2013632. https:\/\/doi.org\/10.1021\/acs.jproteome.8b00702","journal-title":"J Proteome Res"},{"issue":"1","key":"2128_CR30","doi-asserted-by":"publisher","first-page":"a009316","DOI":"10.1101\/cshperspect.a009316","volume":"1","author":"K Tieu","year":"2011","unstructured":"Tieu K (2011) A guide to neurotoxic animal models of Parkinson's disease. Cold Spring Harbor Perspect Med 1(1):a009316. https:\/\/doi.org\/10.1101\/cshperspect.a009316","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"2128_CR31","doi-asserted-by":"publisher","first-page":"175909141877743","DOI":"10.1177\/1759091418777438","volume":"10","author":"X Zeng","year":"2018","unstructured":"Zeng X, Geng W, Jia J (2018) Neurotoxin-induced animal models of Parkinson disease: pathogenic mechanism and assessment. ASN Neuro 10:1759091418777438. https:\/\/doi.org\/10.1177\/1759091418777438","journal-title":"ASN Neuro"},{"issue":"1","key":"2128_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/cpns.88","volume":"91","author":"M Airavaara","year":"2020","unstructured":"Airavaara M, Parkkinen I, Konovalova J, Albert K, Chmielarz P, Domanskyi A (2020) Back and to the future: From neurotoxin-induced to human Parkinson's disease models. Curr Protocols Neurosci 91(1):e88. https:\/\/doi.org\/10.1002\/cpns.88","journal-title":"Curr Protocols Neurosci"},{"issue":"4","key":"2128_CR33","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/cns.12824","volume":"24","author":"V G\u00f3mez-Pineda","year":"2018","unstructured":"G\u00f3mez-Pineda V, Torres-Cruz F, Vivar-Cort\u00e9s C, Hern\u00e1ndez-Echeagaray E (2018) Neurotrophin-3 restores synaptic plasticity in the striatum of a mouse model of Huntington's disease. CNS Neurosci Ther 24(4):353\u2013363. https:\/\/doi.org\/10.1111\/cns.12824","journal-title":"CNS Neurosci Ther"},{"issue":"5","key":"2128_CR34","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s10616-017-0175-3","volume":"70","author":"K Liu","year":"2018","unstructured":"Liu K, Zhang W, Li Y, Ding Q, Bai Y, Wang F, Xu G (2018) Human peripheral blood-derived mesenchymal stem cells with NTRK1 over-expression enhance repairing capability in a rat model of Parkinson's disease. Cytotechnology 70(5):1291\u20131299. https:\/\/doi.org\/10.1007\/s10616-017-0175-3","journal-title":"Cytotechnology"},{"key":"2128_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.brainresbull.2017.03.003","volume":"136","author":"I Song","year":"2018","unstructured":"Song I, Dityatev A (2018) Crosstalk between glia, extracellular matrix and neurons. Brain Res Bull 136:101\u2013108. https:\/\/doi.org\/10.1016\/j.brainresbull.2017.03.003","journal-title":"Brain Res Bull"},{"issue":"11","key":"2128_CR36","doi-asserted-by":"publisher","first-page":"E2253","DOI":"10.1073\/pnas.1616892114","volume":"114","author":"A Dunn","year":"2017","unstructured":"Dunn A, Stout K, Ozawa M, Lohr K, Hoffman C, Bernstein A, Li Y, Wang M et al (2017) Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease. Proc Natl Acad Sci U S A 114(11):E2253\u2013E2262. https:\/\/doi.org\/10.1073\/pnas.1616892114","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2128_CR37","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.18632\/aging.100924","volume":"8","author":"M Cescon","year":"2016","unstructured":"Cescon M, Chen P, Castagnaro S, Gregorio I, Bonaldo P (2016) Lack of collagen VI promotes neurodegeneration by impairing autophagy and inducing apoptosis during aging. Aging 8(5):1083\u20131101. https:\/\/doi.org\/10.18632\/aging.100924","journal-title":"Aging"},{"key":"2128_CR38","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuroscience.2011.03.057","volume":"183","author":"I Cheng","year":"2011","unstructured":"Cheng I, Lin Y, Hwang E, Huang H, Chang W, Liu Y, Chao C (2011) Collagen VI protects against neuronal apoptosis elicited by ultraviolet irradiation via an Akt\/phosphatidylinositol 3-kinase signaling pathway. Neuroscience 183:178\u2013188. https:\/\/doi.org\/10.1016\/j.neuroscience.2011.03.057","journal-title":"Neuroscience"},{"issue":"2","key":"2128_CR39","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nn.2240","volume":"12","author":"J Cheng","year":"2009","unstructured":"Cheng J, Dubal D, Kim D, Legleiter J, Cheng I, Yu G, Tesseur I, Wyss-Coray T et al (2009) Collagen VI protects neurons against Abeta toxicity. Nat Neurosci 12(2):119\u2013121. https:\/\/doi.org\/10.1038\/nn.2240","journal-title":"Nat Neurosci"},{"issue":"2","key":"2128_CR40","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1021\/acschemneuro.8b00454","volume":"10","author":"S Zhang","year":"2019","unstructured":"Zhang S, Wang R, Wang G (2019) Impact of dopamine oxidation on dopaminergic Neurodegeneration. ACS Chem Neurosci 10(2):945\u2013953. https:\/\/doi.org\/10.1021\/acschemneuro.8b00454","journal-title":"ACS Chem Neurosci"},{"issue":"5","key":"2128_CR41","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1111\/j.1471-4159.2009.06404.x","volume":"111","author":"D-Y Hwang","year":"2009","unstructured":"Hwang D-Y, Hong S, Jeong J-W, Choi S, Kim H, Kim J, Kim K-S (2009) Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neurons. J Neurochem 111(5):1202\u20131212. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06404.x","journal-title":"J Neurochem"},{"key":"2128_CR42","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.neulet.2018.10.020","volume":"690","author":"T Shishido","year":"2019","unstructured":"Shishido T, Nagano Y, Araki M, Kurashige T, Obayashi H, Nakamura T, Takahashi T, Matsumoto M et al (2019) Synphilin-1 has neuroprotective effects on MPP-induced Parkinson's disease model cells by inhibiting ROS production and apoptosis. Neurosci Lett 690:145\u2013150. https:\/\/doi.org\/10.1016\/j.neulet.2018.10.020","journal-title":"Neurosci Lett"},{"issue":"2","key":"2128_CR43","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/path.5312","volume":"249","author":"S Stott","year":"2019","unstructured":"Stott S, Randle S, Rawi SA, Rowicka P, Harris R, Mason B, Xia J, Dalley J et al (2019) Loss of FBXO7 results in a Parkinson's-like dopaminergic degeneration via an RPL23-MDM2-TP53 pathway. J Pathol 249(2):241\u2013254. https:\/\/doi.org\/10.1002\/path.5312","journal-title":"J Pathol"},{"issue":"4","key":"2128_CR44","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1001\/jamaneurol.2013.6222","volume":"71","author":"JM Shulman","year":"2014","unstructured":"Shulman JM, Yu L, Buchman AS, Evans DA, Schneider JA, Bennett DA, De Jager PL (2014) Association of Parkinson disease risk loci with mild parkinsonian signs in older persons. JAMA Neurol 71(4):429\u2013435. https:\/\/doi.org\/10.1001\/jamaneurol.2013.6222","journal-title":"JAMA Neurol"},{"issue":"9","key":"2128_CR45","doi-asserted-by":"publisher","first-page":"6775","DOI":"10.1007\/s12035-016-0190-y","volume":"54","author":"A Alieva","year":"2017","unstructured":"Alieva A, Filatova E, Kolacheva A, Rudenok M, Slominsky P, Ugrumov M, Shadrina M (2017) Transcriptome profile changes in mice with MPTP-induced early stages of Parkinson's disease. Mol Neurobiol 54(9):6775\u20136784. https:\/\/doi.org\/10.1007\/s12035-016-0190-y","journal-title":"Mol Neurobiol"},{"issue":"1","key":"2128_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ejn.13760","volume":"47","author":"G Borrageiro","year":"2018","unstructured":"Borrageiro G, Haylett W, Seedat S, Kuivaniemi H, Bardien S (2018) A review of genome-wide transcriptomics studies in Parkinson's disease. Eur J Neurosci 47(1):1\u201316. https:\/\/doi.org\/10.1111\/ejn.13760","journal-title":"Eur J Neurosci"},{"issue":"3","key":"2128_CR47","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s12035-015-9103-8","volume":"53","author":"C Klemann","year":"2016","unstructured":"Klemann C, Martens GJM, Poelmans G, Visser JE (2016) Validity of the MPTP-treated mouse as a model for Parkinson's disease. Mol Neurobiol 53(3):1625\u20131636. https:\/\/doi.org\/10.1007\/s12035-015-9103-8","journal-title":"Mol Neurobiol"},{"issue":"1","key":"2128_CR48","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1750-3639.2008.00171.x","volume":"19","author":"K Bossers","year":"2009","unstructured":"Bossers K, Meerhoff G, Balesar R, van Dongen JW, Kruse CG, Swaab DF, Verhaagen J (2009) Analysis of gene expression in Parkinson's disease: Possible involvement of neurotrophic support and axon guidance in dopaminergic cell death. Brain Pathol 19(1):91\u2013107. https:\/\/doi.org\/10.1111\/j.1750-3639.2008.00171.x","journal-title":"Brain Pathol"},{"issue":"2","key":"2128_CR49","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.nbd.2005.07.010","volume":"21","author":"RM Miller","year":"2006","unstructured":"Miller RM, Kiser GL, Kaysser-Kranich TM, Lockner RJ, Palaniappan C, Federoff HJ (2006) Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson's disease. Neurobiol Dis 21(2):305\u2013313. https:\/\/doi.org\/10.1016\/j.nbd.2005.07.010","journal-title":"Neurobiol Dis"},{"issue":"3","key":"2128_CR50","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1590\/s1679-45082010ao1674","volume":"8","author":"PM Aguiar","year":"2010","unstructured":"Aguiar PM, Severino P (2010) Biomarkers in Parkinson disease: Global gene expression analysis in peripheral blood from patients with and without mutations in PARK2 and PARK8. Einstein (Sao Paulo) 8(3):291\u2013297. https:\/\/doi.org\/10.1590\/s1679-45082010ao1674","journal-title":"Einstein (Sao Paulo)"},{"key":"2128_CR51","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12920-016-0173-x","volume":"9","author":"M Cruz-Monteagudo","year":"2016","unstructured":"Cruz-Monteagudo M, Borges F, Paz YMC, Cordeiro MN, Rebelo I, Perez-Castillo Y, Helguera AM, S\u00e1nchez-Rodr\u00edguez A et al (2016) Efficient and biologically relevant consensus strategy for Parkinson's disease gene prioritization. BMC Med Genet 9:12. https:\/\/doi.org\/10.1186\/s12920-016-0173-x","journal-title":"BMC Med Genet"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-02128-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-020-02128-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-02128-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T02:22:00Z","timestamp":1632968520000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-020-02128-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,30]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["2128"],"URL":"https:\/\/doi.org\/10.1007\/s12035-020-02128-5","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,30]]},"assertion":[{"value":"24 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All animal experiments were performed according the Institutional Animal Care and use guidelines of Nanjing University of Chinese Medicine and approved ethically by the Administration Committee of Experimental Animals, Jiangsu Province, China.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}]}}